  0 Table of Contents |
  1 Home |
| 2 Libraries |
| 3 Measures |
| 4 Downloads |
 5 Artifacts Summary |
  5.1 Excessive Radiation Dose or Inadequate Image Quality for Diagnostic Computed Tomography in Adults - Facility OQR FHIR |
  5.1.1 Library |
| 5.2 Excessive Radiation Dose or Inadequate Image Quality for Diagnostic Computed Tomography in Adults - Clinician FHIR |
| 5.2.1 Library |
| 5.3 Excessive Radiation Dose or Inadequate Image Quality for Diagnostic Computed Tomography in Adults - Facility IQR FHIR |
| 5.3.1 Library |
| 5.4 Anticoagulation Therapy for Atrial Fibrillation/FlutterFHIR |
| 5.4.1 Library |
| 5.5 Antidepressant Medication ManagementFHIR |
| 5.5.1 Library |
| 5.6 Antithrombotic Therapy By End of Hospital Day 2FHIR |
| 5.6.1 Library |
| 5.7 Appropriate Use of DXA Scans in Women Under 65 Years Who Do Not Meet the Risk Factor Profile for Osteoporotic FractureFHIR |
| 5.7.1 Library |
| 5.8 Appropriate Testing for PharyngitisFHIR |
| 5.8.1 Library |
| 5.9 Appropriate Treatment for ST-Segment Elevation Myocardial Infarction (STEMI) Patients in the Emergency Department (ED)FHIR |
| 5.9.1 Library |
| 5.10 Appropriate Treatment for Upper Respiratory Infection (URI)FHIR |
| 5.10.1 Library |
| 5.11 Bone Density Evaluation for Patients with Prostate Cancer and Receiving Androgen Deprivation TherapyFHIR |
| 5.11.1 Library |
| 5.12 Breast Cancer ScreeningFHIR |
| 5.12.1 Library |
| 5.13 Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF less than or equal to 40%)FHIR |
| 5.13.1 Library |
| 5.14 Closing the Referral Loop: Receipt of Specialist ReportFHIR |
| 5.14.1 Library |
| 5.15 Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract SurgeryFHIR |
| 5.15.1 Library |
| 5.16 Cervical Cancer ScreeningFHIR |
| 5.16.1 Library |
| 5.17 Cesarean BirthFHIR |
| 5.17.1 Library |
| 5.18 Child and Adolescent Major Depressive Disorder (MDD): Suicide Risk AssessmentFHIR |
| 5.18.1 Library |
| 5.19 Childhood Immunization StatusFHIR |
| 5.19.1 Library |
| 5.20 Children Who Have Dental Decay or CavitiesFHIR |
| 5.20.1 Library |
| 5.21 Chlamydia Screening in WomenFHIR |
| 5.21.1 Library |
| 5.22 Colorectal Cancer ScreeningFHIR |
| 5.22.1 Library |
| 5.23 Controlling High Blood PressureFHIR |
| 5.23.1 Library |
| 5.24 Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes CareFHIR |
| 5.24.1 Library |
| 5.25 Dementia: Cognitive AssessmentFHIR |
| 5.25.1 Library |
| 5.26 Depression Remission at Twelve MonthsFHIR |
| 5.26.1 Library |
| 5.27 Diabetes: Eye ExamFHIR |
| 5.27.1 Library |
| 5.28 Diabetes: Glycemic Status Assessment Greater Than 9%FHIR |
| 5.28.1 Library |
| 5.29 Discharged on Antithrombotic TherapyFHIR |
| 5.29.1 Library |
| 5.30 Documentation of Current Medications in the Medical RecordFHIR |
| 5.30.1 Library |
| 5.31 Falls: Screening for Future Fall RiskFHIR |
| 5.31.1 Library |
| 5.32 Follow-Up Care for Children Prescribed ADHD Medication (ADD)FHIR |
| 5.32.1 Library |
| 5.33 Functional Status Assessment for Total Hip ReplacementFHIR |
| 5.33.1 Library |
| 5.34 Functional Status Assessments for Heart FailureFHIR |
| 5.34.1 Library |
| 5.35 Global Malnutrition Composite ScoreFHIR |
| 5.35.1 Library |
| 5.36 Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)FHIR |
| 5.36.1 Library |
| 5.37 Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)FHIR |
| 5.37.1 Library |
| 5.38 HIV Annual Retention in CareFHIR |
| 5.38.1 Library |
| 5.39 Sexually Transmitted Infection (STI) Testing for People with HIVFHIR |
| 5.39.1 Library |
| 5.40 HIV ScreeningFHIR |
| 5.40.1 Library |
| 5.41 HIV Viral SuppressionFHIR |
| 5.41.1 Library |
| 5.42 Hospital Harm - Acute Kidney InjuryFHIR |
| 5.42.1 Library |
| 5.43 Hospital Harm - Severe HyperglycemiaFHIR |
| 5.43.1 Library |
| 5.44 Hospital Harm - Opioid-Related Adverse EventsFHIR |
| 5.44.1 Library |
| 5.45 Hospital Harm - Pressure InjuryFHIR |
| 5.45.1 Library |
| 5.46 Hospital Harm - Severe HypoglycemiaFHIR |
| 5.46.1 Library |
| 5.47 Core Clinical Data Elements for the Hybrid Hospital Wide All Condition All Procedure Risk Standardized Mortality Measure HWMFHIR |
| 5.47.1 Library |
| 5.48 Core Clinical Data Elements for the Hybrid Hospital Wide Readmission Measure with Claims and Electronic Health Record Data HWRFHIR |
| 5.48.1 Library |
| 5.49 Initiation and Engagement of Substance Use Disorder TreatmentFHIR |
| 5.49.1 Library |
| 5.50 Intensive Care Unit Venous Thromboembolism ProphylaxisFHIR |
| 5.50.1 Library |
| 5.51 Intravesical Bacillus-Calmette-Guerin for Non-Muscle Invasive Bladder CancerFHIR |
| 5.51.1 Library |
| 5.52 Kidney Health EvaluationFHIR |
| 5.52.1 Library |
| 5.53 Oncology: Medical and Radiation Pain Intensity QuantifiedFHIR |
| 5.53.1 Library |
| 5.54 Preventive Care and Screening Body Mass Index Screening and Follow Up PlanFHIR |
| 5.54.1 Library |
| 5.55 Preventive Care and Screening Screening for High Blood Pressure and Follow Up DocumentedFHIR |
| 5.55.1 Library |
| 5.56 Preventive Care and Screening: Screening for Depression and Follow-Up PlanFHIR |
| 5.56.1 Library |
| 5.57 Primary Open-Angle Glaucoma (POAG): Optic Nerve EvaluationFHIR |
| 5.57.1 Library |
| 5.58 Preventive Care and Screening: Tobacco Use: Screening and Cessation InterventionFHIR |
| 5.58.1 Library |
| 5.59 Primary Caries Prevention Intervention as Offered by DentistsFHIR |
| 5.59.1 Library |
| 5.60 Prostate Cancer Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer PatientsFHIR |
| 5.60.1 Library |
| 5.61 Safe Use of Opioids Concurrent PrescribingFHIR |
| 5.61.1 Library |
| 5.62 Severe Obstetric ComplicationsFHIR |
| 5.62.1 Library |
| 5.63 Statin Therapy for the Prevention and Treatment of Cardiovascular DiseaseFHIR |
| 5.63.1 Library |
| 5.64 Urinary Symptom Score Change 6-12 Months After Diagnosis of Benign Prostatic HyperplasiaFHIR |
| 5.64.1 Library |
| 5.65 Use of High-Risk Medications in Older AdultsFHIR |
| 5.65.1 Library |
| 5.66 Venous Thromboembolism ProphylaxisFHIR |
| 5.66.1 Library |
| 5.67 Weight Assessment and Counseling for Nutrition and Physical Activity for Children/AdolescentsFHIR |
| 5.67.1 Library |
| 5.68 AHAOverall |
| 5.69 ALARACTOQRFHIR |
| 5.70 AdultOutpatientEncounters |
| 5.71 AdvancedIllnessandFrailty |
| 5.72 AlaraCTClinicalFHIR |
| 5.73 AlaraCTIQRFHIR |
| 5.74 AlaraCommonFunctions |
| 5.75 Antibiotic |
| 5.76 AnticoagulationTherapyforAtrialFibrillationFlutterFHIR |
| 5.77 AntidepressantMedicationManagementFHIR |
| 5.78 AntithromboticTherapyByEndofHospitalDay2FHIR |
| 5.79 AppropriateDXAScansForWomenUnder65FHIR |
| 5.80 AppropriateTestingforPharyngitisFHIR |
| 5.81 AppropriateTreatmentforSTEMIFHIR |
| 5.82 AppropriateTreatmentforUpperRespiratoryInfectionURIFHIR |
| 5.83 BoneDensityProstateCancerAndrogenDeprivationTherapyFHIR |
| 5.84 BreastCancerScreeningFHIR |
| 5.85 CADBetaBlockerTherapyPriorMIorLVSDFHIR |
| 5.86 CQMCommon |
| 5.87 CRLReceiptofSpecialistReportFHIR |
| 5.88 Cataracts2040BCVAwithin90DaysFHIR |
| 5.89 CervicalCancerScreeningFHIR |
| 5.90 CesareanBirthFHIR |
| 5.91 ChildandAdolescentMajorDepressiveDisorderMDDSuicideRiskAssessmentFHIR |
| 5.92 ChildhoodImmunizationStatusFHIR |
| 5.93 ChildrenWhoHaveDentalDecayOrCavitiesFHIR |
| 5.94 ChlamydiaScreeninginWomenFHIR |
| 5.95 ColonCancerScreeningFHIR |
| 5.96 ControllingHighBloodPressureFHIR |
| 5.97 CumulativeMedicationDuration |
| 5.98 DRCommunicationWithPhysicianManagingDiabetesFHIR |
| 5.99 DementiaCognitiveAssessmentFHIR |
| 5.100 DepressionRemissionatTwelveMonthsFHIR |
| 5.101 DiabetesEyeExamFHIR |
| 5.102 DiabetesGlycemicStatusAssessmentGreaterThan9PercentFHIR |
| 5.103 DischargedonAntithromboticTherapyFHIR |
| 5.104 DocumentationofCurrentMedicationsFHIR |
| 5.105 FHIRHelpers |
| 5.106 FallsScreeningForFutureFallRiskFHIR |
| 5.107 |
| 5.108 FollowUpCareforChildrenPrescribedADHDMedicationADDFHIR |
| 5.109 FunctionalStatusAssessmentforTotalHipReplacementFHIR |
| 5.110 FunctionalStatusAssessmentsforHeartFailureFHIR |
| 5.111 GlobalMalnutritionCompositeFHIR |
| 5.112 HFACEIorARBorARNIforLVSDFHIR |
| 5.113 HFBetaBlockerTherapyforLVSDFHIR |
| 5.114 HIVRetentionFHIR |
| 5.115 HIVSTITestingFHIR |
| 5.116 HIVScreeningFHIR |
| 5.117 HIVViralSuppressionFHIR |
| 5.118 Hospice |
| 5.119 HospitalHarmAcuteKidneyInjuryFHIR |
| 5.120 HospitalHarmHyperglycemiainHospitalizedPatientsFHIR |
| 5.121 HospitalHarmOpioidRelatedAdverseEventsFHIR |
| 5.122 HospitalHarmPressureInjuryFHIR |
| 5.123 HospitalHarmSevereHypoglycemiaFHIR |
| 5.124 HybridHospitalWideMortalityFHIR |
| 5.125 HybridHospitalWideReadmissionFHIR |
| 5.126 InitiationandEngagementofSubstanceUseDisorderTreatmentFHIR |
| 5.127 IntensiveCareUnitVenousThromboembolismProphylaxisFHIR |
| 5.128 IntravesicalBacillusCalmetteGuerinForBladderCancerFHIR |
| 5.129 KidneyHealthEvaluationFHIR |
| 5.130 OncologyPainIntensityQuantifiedFHIR |
| 5.131 PCMaternal |
| 5.132 PCSBMIScreenAndFollowUpFHIR |
| 5.133 PCSBPScreeningFollowUpFHIR |
| 5.134 PCSDepressionScreenAndFollowUpFHIR |
| 5.135 POAGOpticNerveEvaluationFHIR |
| 5.136 PalliativeCare |
| 5.137 PreventiveCareAndTobaccoUseScreeningAndCessationInterventionFHIR |
| 5.138 PrimaryCariesPreventionasOfferedbyDentistsFHIR |
| 5.139 ProstateCaAvoidanceBoneScanOveruseFHIR |
| 5.140 QICoreCommon |
| 5.141 SafeUseofOpioidsConcurrentPrescribingFHIR |
| 5.142 SevereObstetricComplicationsFHIR |
| 5.143 StatinTherapyforthePreventionandTreatmentofCardiovascularDiseaseFHIR |
| 5.144 Status |
| 5.145 SupplementalDataElements |
| 5.146 TJCOverall |
| 5.147 UrinarySymptomScoreChangeAfterBenignProstaticHyperplasiaFHIR |
| 5.148 UseofHighRiskMedicationsintheElderlyFHIR |
| 5.149 VTE |
| 5.150 VenousThromboembolismProphylaxisFHIR |
| 5.151 WeightAssessmentandCounselingforNutritionandPhysicalActivityforChildrenandAdolescentsFHIR |
|